Azithromycin through the Lens of the COVID-19 Treatment

Azithromycin has become famous in the last two years, not for its main antimicrobial effect, but for its potential use as a therapeutic agent for COVID-19 infection. Initially, there were some promising results that supported its use, but it has become clear that scientific results are insufficient...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Antibiotics
المؤلفون الرئيسيون:	Georgia G. Kournoutou, George Dinos
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2022-08-01
الموضوعات:	macrolides azithromycin virus coronavirus COVID-19 immunolides
الوصول للمادة أونلاين:	https://www.mdpi.com/2079-6382/11/8/1063

مواد مشابهة

AZITHROMYCIN IN THERAPY OF BACTERIAL RHINOSINUSITES
حسب: A. A. Krivopalov, وآخرون
منشور في: (2017-07-01)

A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial
حسب: Timothy S. C. Hinks, وآخرون
منشور في: (2020-08-01)

The effect of erythromycin and clarithromycin versus azithromycin on serum valproate concentration
حسب: Muradi Albanji, وآخرون
منشور في: (2022-04-01)

Synthesis and Antibacterial Activity of ll-O-(Benzoxaborole-Aminoalkylcarbamoyl) Derivatives of Macrolide Antibiotic Azithromycin
حسب: S. S. Printsevskaya, وآخرون
منشور في: (2020-05-01)

Novel Knowledge of Macrolide Resistance in <i>Mycoplasma pneumoniae</i> by Azithromycin Exposure
حسب: Tomohiro Oishi, وآخرون
منشور في: (2024-01-01)

Unprecedented Epimerization of an Azithromycin Analogue: Synthesis, Structure and Biological Activity of 2′-Dehydroxy-5″-Epi-Azithromycin
حسب: Goran Kragol, وآخرون
منشور في: (2022-02-01)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
حسب: Elisa Baranski Lamback, وآخرون
منشور في: (2021-03-01)

Increase in veterinary prescriptions of azithromycin during the COVID-19 pandemic in Brazil
حسب: Fernando de Sá Del Fiol, وآخرون
منشور في: (2023-07-01)

Azithromycin and the Outcome of Treated COVID-19 Patients: A Hospital-Based Study
حسب: Elly Usman
منشور في: (2022-07-01)

Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
حسب: Mondher Toumi, وآخرون
منشور في: (2020-01-01)

AZITHROMYCIN: MODERN PLACE OF THE DRUG IN THERAPY OF LOWER RESPIRATORY TRACTS INFECTIONS
حسب: S. I. Sazhnova, وآخرون
منشور في: (2017-11-01)

Analysis of Azithromycin adverse events in COVID-19 Patients reported to Iraqi Pharmacovigilance center in 2020
حسب: Yasir A. Noori, وآخرون
منشور في: (2022-10-01)

The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis
حسب: Kazunori Nakamura, وآخرون
منشور في: (2023-10-01)

A systematic review and meta-analysis of macrolides in the management of adult patients with asthma
حسب: Hiroshi Ohnishi, وآخرون
منشور في: (2024-07-01)

Increased antimicrobial resistance against azithromycin during COVID: role of irrational utilization
حسب: Sidra Tanwir, وآخرون
منشور في: (2024-01-01)

Effect of hydroxychloroquine and azithromycin combination use in COVID-19 patients – An umbrella review
حسب: Kaushik Nag, وآخرون
منشور في: (2024-01-01)

Impact of Administering Intravenous Azithromycin within 7 Days of Hospitalization for Influenza Virus Pneumonia: A Propensity Score Analysis Using a Nationwide Administrative Database
حسب: Takatomo Tokito, وآخرون
منشور في: (2023-05-01)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
حسب: Nobuaki Mori, وآخرون
منشور في: (2021-02-01)

Impact of oral azithromycin and intermittent preventive treatment with sulfadoxine-pyrimethamine regimen on child mortality in Sierra Leone: trial protocol for a randomised, two-arm, double-blinded, placebo-controlled clinical trial (ICARIA)
حسب: Kwabena Owusu-kyei, وآخرون
منشور في: (2024-09-01)

Azithromycin in the complex therapy of COVID-19. Advantages and effectiveness of the use of the dispersed form in outpatient settings
حسب: D. S. Sukhanov, وآخرون
منشور في: (2021-10-01)

Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease
حسب: Maria Bergami, وآخرون
منشور في: (2023-07-01)

ACUTE RESPIRATORY INFECTIONS IN CHILDREN WITH ALLERGY: PROBLEMS WITH ANTIBACTERIAL AGENT CHOICE
حسب: O. V. Zaitseva
منشور في: (2013-02-01)

Macrolide Antibiotic Mediated Cardiac Arrhythmias: Emerging Concepts and Clinical Implications
حسب: Fatima Iqbal, وآخرون
منشور في: (2025-06-01)

Effects of cardiac toxicity of combination therapy with hydroxychloroquine and azithromycin in COVID-19 patients
حسب: Usha Yendrapalli, وآخرون
منشور في: (2021-11-01)

Azithromycin for COVID-19: Pharmacological Mechanisms, Challenges, and Prospects
حسب: Parisa Saberi-Hasanabadi, وآخرون
منشور في: (2023-12-01)

Approaches to Assessing the Safety of Medicines during the COVID-19 Pandemic Using the Example of Azithromycin
حسب: Yu. M. Gomon, وآخرون
منشور في: (2022-10-01)

National trends in Azithromycin consumption during 2017–2023 in Kazakhstan: impact of the COVID-19 pandemic and the imperative for enhanced clinical guidelines
حسب: Laura Kassym, وآخرون
منشور في: (2025-02-01)

Azithromycin use before and during the COVID- 19 pandemic and the impact of implementing national evidence-based guidelines in Qatar
حسب: Adeel A. Butt, وآخرون
منشور في: (2024-11-01)

Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials
حسب: Nathália Mariana Santos Sansone, وآخرون
منشور في: (2024-09-01)

Sars-Cov-2 Infection in Patients on Long-Term Treatment with Macrolides in Spain: A National Cross-Sectional Study
حسب: Carmen Marina Meseguer Barros, وآخرون
منشور في: (2021-08-01)

AZTEC—azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes
حسب: Tin Man Mandy Lau, وآخرون
منشور في: (2022-08-01)

Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients
حسب: Philippe Brouqui, وآخرون
منشور في: (2023-10-01)

Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
حسب: Lagier JC, وآخرون
منشور في: (2022-05-01)

FEATURES OF THE PROGRESSION AND TREATMENT OF RESPIRATORY INFECTIONS IN CHILDREN WITH ALLERGIES
حسب: M. S. Savenkova, وآخرون
منشور في: (2014-10-01)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
حسب: Matthieu Million, وآخرون
منشور في: (2023-04-01)

Efficacy and safety of in-hospital treatment of Covid-19 infection with low-dose hydroxychloroquine and azithromycin in hospitalized patients: A retrospective controlled cohort study
حسب: Gert Meeus, وآخرون
منشور في: (2023-10-01)

FIVE REASONS TO PRESCRIBE A MACROLIDE FOR ENT DISEASE
حسب: V. V. SHILENKOVA
منشور في: (2016-12-01)

Macrolide Allergic Reactions
حسب: Kristy M. Shaeer, وآخرون
منشور في: (2019-09-01)

Therapeutic study of rosacea by Azithromycin and Metronidazole
حسب: Naseer A. Al-harchan
منشور في: (2010-01-01)

Efficacy of azithromycin in the treatment of cutaneous leishmaniasis
حسب: Seyyed Mohammad Alavi (MD), وآخرون
منشور في: (2009-03-01)